-
公开(公告)号:JP2012246303A
公开(公告)日:2012-12-13
申请号:JP2012180374
申请日:2012-08-16
Inventor: CONTE AURELIA , KUEHNE HOLGER , LUEBBERS THOMAS , MATTEI PATRIZIO , MAUGEAIS CYRILLE , MUELLER WERNER , PFLIEGER PHILIPPE
IPC: C07C233/65 , A61K31/166 , A61K31/415 , A61K31/44 , A61K31/455 , A61K31/505 , A61K31/695 , A61P3/04 , A61P3/06 , A61P3/10 , A61P9/04 , A61P9/10 , A61P9/12 , A61P43/00 , C07C233/66 , C07C233/73 , C07D213/81 , C07D213/82 , C07D233/68 , C07D239/28
CPC classification number: C07C233/66 , C07C233/65 , C07C233/73 , C07C2601/02 , C07C2601/04 , C07D213/40 , C07D213/61 , C07D213/81 , C07D213/82 , C07D231/16 , C07D239/28 , C07F7/0818
Abstract: PROBLEM TO BE SOLVED: To provide novel benzamide and heteroarene derivatives, methods for producing them, use of them as pharmaceuticals, and pharmaceutical compositions including them.SOLUTION: Compounds represented by formula (I) and pharmaceutically acceptable salts thereof are provided. In the formula: Ris 1-6C alkyl or the like; Ris hydrogen or the like; Ris hydrogen, 1-6C alkyl or the like, Ris hydrogen or the like; A is CRor N, B is CRor N, and D is CRor N where -B=A- and -A=D- are not -N=N-, Ris hydrogen, 1-6C alkyl or the like, and Rand Rare hydrogen or the like; and n is 1, 2, or 3.
Abstract translation: 要解决的问题:提供新的苯甲酰胺和杂芳烃衍生物,其制备方法,它们作为药物的用途,以及包括它们的药物组合物。 解决方案:提供由式(I)表示的化合物及其药学上可接受的盐。 在下式中:R 1 = C 1-6烷基等; R
2 SP>是氢等; 4 SP>是氢,1-6C烷基等,R 4是氢或类似物; A为CR 10 SP>或N,B为CR 11 SP>或N,D为CR 3 SP>或N其中-B = A-和-A = D-不是-N = N-,R 3是氢,1-6C烷基或 例如,R 10 SP>和R 11 SP>是氢等; 而且n为1,2或3.版权所有(C)2013,JPO&INPIT -
2.Anthranilamide/2-amino-heteroarene carboxamide derivative 审中-公开
Title translation: 苯胺甲酰胺/ 2-氨基异恶唑羧酰胺衍生物公开(公告)号:JP2013056894A
公开(公告)日:2013-03-28
申请号:JP2012226826
申请日:2012-10-12
Inventor: CONTE AURELIA , KUEHNE HOLGER , LUEBBERS THOMAS , MATTEI PATRIZIO , MAUGEAIS CYRILLE , MUELLER WERNER , PFLIEGER PHILIPPE
IPC: C07C237/30 , A61K31/166 , A61K31/192 , A61K31/216 , A61K31/275 , A61K31/381 , A61K31/415 , A61K31/417 , A61K31/425 , A61K31/426 , A61K31/4418 , A61K31/4427 , A61K31/455 , A61K31/4965 , A61K31/50 , A61K31/505 , A61P3/04 , A61P3/06 , A61P3/10 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P43/00 , C07C231/02 , C07C237/32 , C07C237/34 , C07C237/42 , C07C253/30 , C07C255/24 , C07C255/57 , C07C269/06 , C07C271/28 , C07C303/30 , C07C303/40 , C07C309/66 , C07C311/08 , C07D213/61 , C07D213/81 , C07D213/82 , C07D231/12 , C07D231/16 , C07D233/64 , C07D237/24 , C07D239/32 , C07D241/28 , C07D261/14 , C07D263/38 , C07D275/02 , C07D277/20 , C07D277/42 , C07D333/38 , C07D401/12 , C07F7/12
CPC classification number: C07D213/82 , C07C237/30 , C07C237/32 , C07C255/25 , C07C255/54 , C07C271/28 , C07C309/66 , C07C311/08 , C07C2601/02 , C07C2601/04 , C07C2601/06 , C07D231/14 , C07D261/18 , C07D275/03 , C07D333/38 , C07D401/12 , C07D403/12 , C07F7/0818
Abstract: PROBLEM TO BE SOLVED: To provide novel anthranilamide and 2-amino-heteroarene carboxamide derivatives useful as cholesteryl ester transfer protein (CETP) inhibitors; methods for producing the same; use thereof as pharmaceuticals; and pharmaceutical compositions including the same.SOLUTION: The novel anthranilamide and 2-amino-heteroarene carboxamide derivatives are compounds typified by 5-chloro-N-(4-cyclopentyl-benzyl)-2-isopropylamino-N-[2-(3-trifluoromethyl-phenyl)-ethyl]-benzamide or N-(4-tert-butyl-benzyl)-N-2-(3,4-dichloro-phenyl)-ethyl-2-methylamino-nicotinamide and represented by formula I.
Abstract translation: 要解决的问题:提供用作胆固醇酯转移蛋白(CETP)抑制剂的新型邻氨基苯甲酰胺和2-氨基 - 杂芳酰胺酰胺衍生物; 生产方法; 作为药物使用; 和包含其的药物组合物。 解决方案:新颖的邻氨基苯甲酰胺和2-氨基 - 杂芳酰胺衍生物是以5-氯-N-(4-环戊基 - 苄基)-2-异丙基氨基-N- [2-(3-三氟甲基 - 苯基) - 乙基] - 苯甲酰胺或N-(4-叔丁基 - 苄基)-N-2-(3,4-二氯 - 苯基) - 乙基-2-甲基氨基 - 烟酰胺,由式I表示。 (C)2013,JPO&INPIT
-
公开(公告)号:KR20180054635A
公开(公告)日:2018-05-24
申请号:KR20187008127
申请日:2016-09-21
Applicant: HOFFMANN LA ROCHE
Inventor: MATTEI PATRIZIO , HERT JEROME , HUNZIKER DANIEL , RUDOLPH MARKUS , SCHMITZ PETRA , DI GIORGIO PATRICK
IPC: C07D487/04 , A61K31/407 , A61K31/437 , A61K31/5517 , A61P27/02 , C07D471/04
CPC classification number: C07D471/04
Abstract: 본발명은신규한하기화학식 I의화합물, 상기화합물을포함하는조성물, 및상기화합물의사용방법을제공한다: [화학식 I]상기식에서, R, R, Y, W, m, n, p 및 q는본원에정의된바와같다.
-
公开(公告)号:KR20180053408A
公开(公告)日:2018-05-21
申请号:KR20187011566
申请日:2016-09-20
Applicant: HOFFMANN LA ROCHE
Inventor: HERT JEROME , HUNZIKER DANIEL , MATTEI PATRIZIO , RUDOLPH MARKUS , SCHMITZ PETRA , ULLMER CHRISTOPH
IPC: C07D487/04 , A61K31/407 , A61P27/02
CPC classification number: C07D487/04
Abstract: 본발명은신규한하기화학식 I의화합물, 상기화합물을포함하는조성물, 및상기화합물의사용방법을제공한다: [화학식 I]상기식에서, R, R, R, Y, W, m, n, p 및 q는본원에정의된바와같다.
-
公开(公告)号:KR20180054830A
公开(公告)日:2018-05-24
申请号:KR20187011565
申请日:2016-09-20
Applicant: HOFFMANN LA ROCHE
Inventor: DI GIORGIO PATRICK , HERT JEROME , HUNZIKER DANIEL , MATTEI PATRIZIO , RUDOLPH MARKUS , SCHMITZ PETRA
IPC: C07D487/04 , A61K31/407 , A61P27/02
CPC classification number: C07D487/04 , C07D519/00
Abstract: 본발명은신규한하기화학식 I의화합물, 상기화합물을포함하는조성물, 및상기화합물의사용방법을제공한다: [화학식 I]상기식에서, R, R, R, Y, W, m, n, p 및 q는본원에정의된바와같다.
-
公开(公告)号:KR20180054634A
公开(公告)日:2018-05-24
申请号:KR20187008126
申请日:2016-09-21
Applicant: HOFFMANN LA ROCHE
Inventor: DI GIORGIO PATRICK , HERT JEROME , HUNZIKER DANIEL , MATTEI PATRIZIO , RUDOLPH MARKUS , SCHMITZ PETRA , ULLMER CHRISTOPH
IPC: C07D487/04 , A61K31/407 , A61K31/437 , A61K31/5517 , A61P27/02 , C07D471/04
CPC classification number: C07D487/04 , A61K31/407 , A61K31/437 , A61K31/5517 , C07D471/04
Abstract: 본발명은신규한하기화학식 I의화합물, 상기화합물을포함하는조성물, 및상기화합물의사용방법을제공한다: [화학식 I]상기식에서, R, R, Y, W, m, n, p 및 q는본원에정의된바와같다.
-
公开(公告)号:KR20180043837A
公开(公告)日:2018-04-30
申请号:KR20187009433
申请日:2016-09-01
Applicant: HOFFMANN LA ROCHE
Inventor: HERT JEROME , HUNZIKER DANIEL , KUEHNE HOLGER , LUEBBERS THOMAS , MARTIN RAINER E , MATTEI PATRIZIO , NEIDHART WERNER , RICHTER HANS , RUDOLPH MARKUS , PINARD EMMANUEL
IPC: C07D249/12 , A61K31/4196 , A61K31/4245 , A61P27/02 , A61P27/06 , C07D403/12 , C07D413/12
CPC classification number: C07D403/12 , C07D231/12 , C07D231/56 , C07D237/14 , C07D249/12 , C07D401/12 , C07D407/04 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D487/04 , C07F7/0812
Abstract: 본발명은하기화학식 (I)의신규화합물, 상기화합물을포함하는조성물, 및상기화합물의사용방법을제공한다:(I) 상기식에서, R, R, R, R및 W는본원명세서에정의된바와같다.
-
8.
公开(公告)号:WO2017050791A8
公开(公告)日:2017-07-06
申请号:PCT/EP2016072347
申请日:2016-09-21
Applicant: F HOFFMANN-LA ROCHE AG , HOFFMANN-LA ROCHE INC
Inventor: DI GIORGIO PATRICK , HERT JÉRÔME , HUNZIKER DANIEL , MATTEI PATRIZIO , RUDOLPH MARKUS , SCHMITZ PETRA , ULLMER CHRISTOPH
IPC: C07D471/04 , A61K31/407 , A61K31/437 , A61K31/5517 , A61P1/00 , A61P25/00 , A61P29/00 , A61P37/00 , C07D487/04
CPC classification number: C07D487/04 , A61K31/407 , A61K31/437 , A61K31/5517 , C07D471/04
Abstract: The invention provides novel compounds having the general formula (I) wherein R1, R2,Y, W, m, n, p and q are as defined herein, compositions including the compounds and methods of using the compounds.
Abstract translation: 本发明提供具有通式(I)的新化合物,其中R 1,R 2,Y,W,m,n,p和q如本文所定义,包括所述化合物的组合物和使用所述化合物的方法。
-
9.
公开(公告)号:WO2012117000A8
公开(公告)日:2013-03-07
申请号:PCT/EP2012053386
申请日:2012-02-29
Applicant: HOFFMANN LA ROCHE , BISSANTZ CATERINA , DEHMLOW HENRIETTA , ERICKSON SHAWN DAVID , KARNACHI PRABHA SABA , KIM KYUNGJIN , MARTIN RAINER E , MATTEI PATRIZIO , OBST SANDER ULRIKE , PIETRANICO-COLE SHERRIE LYNN , RICHTER HANS , ULLMER CHRISTOPH
Inventor: BISSANTZ CATERINA , DEHMLOW HENRIETTA , ERICKSON SHAWN DAVID , KARNACHI PRABHA SABA , KIM KYUNGJIN , MARTIN RAINER E , MATTEI PATRIZIO , OBST SANDER ULRIKE , PIETRANICO-COLE SHERRIE LYNN , RICHTER HANS , ULLMER CHRISTOPH
IPC: C07D213/75 , A61K31/4418 , A61K31/4433 , C07D213/81 , C07D213/82 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/12 , C07D413/04 , C07D413/12 , C07D417/04 , C07D417/12 , C07D491/107
CPC classification number: C07D213/75 , C07D213/81 , C07D213/82 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/04 , C07D405/12 , C07D413/04 , C07D413/12 , C07D417/04 , C07D417/12 , C07D491/107
Abstract: This invention relates to novel 3-aminopyridines of the formula (I) wherein B1, B2 and R1 to R6 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.
Abstract translation: 本发明涉及式(I)的新的3-氨基吡啶,其中B1,B2和R1至R6如说明书和权利要求书中所定义,以及其药学上可接受的盐。 这些化合物是GPBAR1激动剂,可用作治疗II型糖尿病等疾病的药物。
-
10.
公开(公告)号:WO2007090749A3
公开(公告)日:2007-11-29
申请号:PCT/EP2007050812
申请日:2007-01-29
Applicant: HOFFMANN LA ROCHE , FAEH CHRISTOPH , KUEHNE HOLGER , LUEBBERS THOMAS , MATTEI PATRIZIO , MAUGEAIS CYRILLE , PFLIEGER PHILIPPE
Inventor: FAEH CHRISTOPH , KUEHNE HOLGER , LUEBBERS THOMAS , MATTEI PATRIZIO , MAUGEAIS CYRILLE , PFLIEGER PHILIPPE
IPC: C07D213/40 , A61K31/4402 , C07D213/82 , C07D233/28 , C07D233/58 , C07D233/60 , C07D401/12 , C07D405/12 , C07D409/12 , C07D417/12
CPC classification number: C07D405/12 , C07D213/40 , C07D213/82 , C07D277/28 , C07D333/58 , C07D333/60 , C07D401/12 , C07D409/12 , C07D417/12
Abstract: Compounds of formula (I) processes for their preparation, their use as pharmaceuticals and to pharmaceutical compositions comprising them.
Abstract translation: 式(I)化合物的制备方法,它们作为药物的用途以及包含它们的药物组合物。
-
-
-
-
-
-
-
-
-